Contact

 

 

Team Bestedingen

If you have any questions, please contact our Scientific Review and Grants Administration (Team Bestedingen). They are happy to help you with the administrational procedures regarding research project proposals.
 
T: +31 20 - 570 04 50
 

Programme coordinators

Team Bestedingen can submit specific questions regarding your research project to a programme coordinator (see below). They can offer support in overcoming bottlenecks and connect parties that could synergistically enhance the research & development outcomes.  

Dr. Laurien Hoefnagel - Programme coordinator Biomarkers & Secretary Review Board Development & Implementation

 
 
Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well the patient responds to therapeutic intervention(s).
 
  

Dr. Miranda Wijdenes - Programme coordinator Biomarkers

 

Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well the patient responds to therapeutic intervention(s).



Dr. Marion Scharpfenecker - Programme coordinator Biomarkers

Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well the patient responds to therapeutic intervention(s).  

 

 

Dr. Sanne Kuijper - Programme coordinator NKI & Basic Research 


Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.
 


 
Dr. Nora Liu - Programme coordinator Basic Research 

 
Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.
 



Dr. Maaike Alderliesten - Programme coordinator Imaging 

A type of test (i.e. CT, MRI, ultrasound) that makes detailed pictures of areas inside the body. Imaging tests use different forms of energy, such as x-rays (high-energy radiation), ultrasound (high-energy sound waves), radio waves, and radioactive substances. They may be used to help diagnose disease, plan treatment, or find out how well treatment is working. 
 

 Drs. Maarten van den Ende - Programme coordinator Agents 

 
Drugs or biologicals used to prevent or inhibit the proliferation of cancerous cells. Examples of agents are small molecules, therapeutic enzymes and hormones.
 

 

  

Drs. Fleur Huijsman - Programme coordinator Lifestyle and Exposure 

The influence of behaviour or (unwanted) exposure to exogenous factors (other than factors belonging to oncological treatment) on the development, the recurrence, the aggravation, or the prevention of cancer, and/or the development, the aggravation, or the prevention of side effects from cancer (treatment). 
 


Dr. Yuri Souwer - Programme coordinator Immunotherapy

Immunotherapy is immune-based therapy that either stimulates an individual’s immune system so that it will recognize and destroy cancerous cells (also known as “active” immunotherapy, which includes vaccines and cytokine therapy), or a therapy that provides the immune response to the patient (also known as “passive” immunotherapy like monoclonal antibody drugs or adoptive T-cell therapy).

Dr. Ana de Castro - Programme coordinator Infrastructure

Infrastructural initiatives are services, resources and (collaborative) networks used by the research community to support oncology research in order to accelerate and/or optimise the exploitation of results to the patients and public. 

 




Dr. Sigrid Oomen - Programme coordinator Interventive Devices 

Treatment instruments to prevent or treat local-regional sites of cancer or precancerous lesions. The modalities may be delivered non-invasively (e.g. radiation therapy), minimally invasively (e.g.cryoablation, hyperthermia) or by open surgery (invasive).




 

Dr. Renée de Bruin - Programme coordinator Quality of Life 

Quality of Life is the perception of (ex-) cancer patients of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. It is a broad ranging concept, comprising quality of care and effects of cancer and it’s treatment, as well as the (ex-)patient’s physical and cognitive health, psychological state, level of independence, social relationships and personal beliefs. 
 

Dr. Jeroen Dudok- Secretary Review Board Exploration



Secretary of the scientific review board Exploration in which project proposals in the exploration track (basic research and credentialing) are reviewed. Responsible in this position for supporting the board in the review process and monitoring the process and procedures for reviewing project proposals. 

Dr. Mirte Brom - Programme coordinator Implementation

Research and activities required for the realization of the implementation of concrete applications into oncology policy and practice with demonstrable added value compared to the current practice, at national level. Implementation focuses on the actions of healthcare professionals and other stakeholders as a key variable in the sustainable implementation of evidence-based interventions.
 

Select the Component and add.
Close

Contact

​For questions please contact Team Bestedingen:bestedingen@kwf.nl
T: +31 20 - 570 04 50